Jeffrey LaRose, Chief Scientific Officer at HeartWare International, Inc. (HTWR), sold 3,072 shares at $72.78 ($224K) on 2014-12-22, disclosed to the SEC on 2014-12-23.
Scheduled sale ($224k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $72.78 | 1,510 | $110K | 49.0% |
| 2 | $73.18 | 1,562 | $114K | 51.0% |
| Total | $72.98 avg | 3,072 | $224K | 100% |
| Filing → |
| HTWR | SELL | 2016-02-09 | $20K | — | Filing → |
| HTWR | SELL | 2015-12-23 | $57K | — | Filing → |
| HTWR | SELL | 2015-02-26 | $30K | — | Filing → |